Is NewAmsterdam Pharma Company N.V. (NAMS) a Buy, Sell, or Hold?
NASDAQ : NAMS
NewAmsterdam Pharma Company N.V. — Analyst Ratings
$27.79 USD
-$0.67 (-2.35%)
- Volume
- 952.3K
- Average Volume
- 1.3M
- Market Capitalization
- $3.25B
- P/E Ratio
- -15.35
- Dividend Yield
- 0.00%
- Price Target
- $48.00
- Year High
- $42.21
- Year Low
- $21.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.76
Analyst Consensus Summary
Consensus Rating
Sell
10 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-42.1%
vs Current Price
Price Target
$48.00
Average TargetPrice Target Range
Lowest Target
$45.00
-38.2% DOWNSIDE
Average Target
$48.00
Median Estimate
Highest Target
$58.00
-52.1% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 10
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 9 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Dennis Ding | $45 | $29.7376 | 2026-07-20 11:36 AM | 51.3% |
| Leerink Partners | Roanna Ruiz | $55 | $33.48 | 2026-01-06 04:33 AM | 64.3% |
| H.C. Wainwright | Joseph Pantginis | $52 | $36.4 | 2025-10-20 06:16 AM | 42.9% |